Last updated on January 2020

A Phase 3, Randomized , Double Blind, Placebo controlled Study. Investigating the Efficacy and Safety of CVT-301 (Levodopa inhalation Powder) in Parkinson's Disease With Motor Response Fluctuations (Off Phenomena)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Parkinson's disease
  • Age: Between 30 - 85 Years
  • Gender: Male or Female

Eligibility Criteria:

  • Be between 30 and 85 years of age
  • Have a medical diagnosis of idiopathic Parkinson's
  • Experience off episodes and show a response to treatment with levodopa
  • Require the use of levodopa-containing medication
  • Be on a stable medication regimen

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.